congenital disorder of glycosylation type IIp
| HPO ID | HPO Term |
|---|---|
| HP:0003141 | Increased LDL cholesterol concentration |
| HP:0001397 | Hepatic steatosis |
| HP:0012358 | Abnormal protein O-linked glycosylation |
| HP:0001263 | Global developmental delay |
| HP:0010837 | Decreased circulating ceruloplasmin concentration |
| HP:0002910 | Elevated circulating hepatic transaminase concentration |
| HP:0000007 | Autosomal recessive inheritance |
| HP:0003155 | Elevated circulating alkaline phosphatase concentration |
| HP:0001410 | Decreased liver function |
| HP:0012347 | Abnormal protein N-linked glycosylation |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025